Covaxin vaccine
- India
Health Ministry rejects claim ‘Covaxin was rushed due to political pressure’
Delhi: The Union Health Ministry on Thursday rejected media reports that Covaxin manufacturer Bharat Biotech skipped certain processes and accelerated clinical trials due to political pressure, calling them “completely misleading, fallacious and…
- Hyderabad
50 mn doses of Covaxin set to expire early 2023 due to poor offtake
Hyderabad: Nearly 50 million doses of Bharat Biotech’s COVID-19 vaccine, Covaxin lying with the firm are set to expire early next year as there are no takers owing to poor demand, company sources…
- Hyderabad
Hyderabad: COVID-19 vaccines stolen from health centre in old city
Hyderabad: A total of 41 Covishield and Covaxin vaccinations were stolen from an Urban Primary Health Centre (UPHC) at Kalikhabar in the old city on Sunday. According to the police, the robbers…
- Featured News
Covaxin-2021–A year of ups and downs or travails and triumphs
M Somasekhar January 1, 2022 rang in some good news for Covaxin, the indigenous vaccine against COVID-19 developed by a consortia led by Bharat Biotech, Hyderabad and National Institute of Virology (NIV),…
- Middle East
COVID-19: Saudi Arabia approves Bharat Biotech’s Covaxin
Riyadh: In a major relief to thousands of non-resident Indians (NRI) in the Kingdom of Saudi Arabia, the Indian embassy in Saudi Arabia on Monday announced that the gulf country has now included…
- India
15 more nations recognise India’s Covid-19 vaccines
New Delhi: Fifteen more countries have recognised India’s Covid-19 vaccination certificate, taking the total number of such nations that have approved India’s vaccine certificate to 21, said the Ministry of External Affairs…
- India
Covaxin 50% effective against Delta variant, shows Lancet study
New Delhi: Two doses of Covaxin are 50 per cent effective against symptomatic COVID-19, according to the first real-world assessment of India’s indigenous coronavirus vaccine published in The Lancet Infectious Diseases journal.…
- India
Major relief to Indians as Bahrain approves Covaxin vaccine
Manama: In a major relief to thousands of non-resident Indians (NRI) in Bahrain, the Indian embassy in Bahrain on Friday announced that the gulf country has now included Bharat Biotech’s Covaxin in…
- World
Bharat Biotech’s Covaxin approved by Hong Kong
Hong Kong: Hong Kong has recognised Hyderabad-based pharmaceutical firm Bharat Biotech’s Covaxin on its approved COVID-19 vaccine list. This comes days after Covaxin received the emergency use listing (EUL) from the World…
- Middle East
Relief to Indians as Oman approves Covaxin vaccine
Muscat: In a major relief to thousands of non-resident Indians (NRI) in Oman, the Indian embassy in Oman on Wednesday announced that the gulf country has now included Bharat Biotech’s Covaxin in…
- News
Covaxin gets emergency use approval for kids aged 2-18 years
New Delhi: The Hyderabad-based pharma major Bharat Biotech’s Covaxin has got the emergency use approval for children in the age group of 2 to 18 years from the Drugs Controller General of…
- India
Final decision on granting clearance to Covaxin next week: WHO
Hyderabad: Officials from the World Health Organisation (WHO) and an independent group of experts will meet next week to carry out a risk/benefit assessment and take a final decision on whether to…
- World
WHO to decide on Bharat Biotech’s Covaxin emergency usage in October
New Delhi: The World Health Organisation (WHO) on Wednesday informed that the final decision on Bharat Biotech’s submission on emergency use listing (EUL) for its Covaxin COVID-19 vaccine will be made in…
- India
Bharat Biotech completes phase 2/3 trials of Covaxin for children
Hyderabad: Bharat Biotech has completed the Phase 2/3 trials of COVID-19 vaccine, Covaxin for use in children under 18 years of age and is expected to submit the data by next week to…
- India
COVID-19: WHO approval for Covaxin expected this week: Sources
New Delhi: The World Health Organisation’s (WHO) approval for Bharat Biotech’s COVID-19 vaccine, Covaxin, is expected this week, sources said on Monday. Bharat Biotech has submitted its Phase 3 clinical trials data…
- 1
- 2